1 / 10

Global Oncology/Cancer Drugs Market Growth 2013-2020

Big Market Research, Global Oncology/Cancer Drugs Market Size, Share, Global Trends, Company Profiles, Product type, Applications, Component, End User, Geography, Demand, Insights, Segmentation and Forecast, 2013 – 2020.Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. Get full report @ http://www.bigmarketresearch.com/oncology-cancer-drugs-market

lisafrenchh
Télécharger la présentation

Global Oncology/Cancer Drugs Market Growth 2013-2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) www.bigmarketresearch.com

  2. Acquired (Autoimmune) Hemolytic Anemia Report Description Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth. Read complete report here @ http://www.bigmarketresearch.com/oncology-cancer-drugs-market

  3. Acquired (Autoimmune) Hemolytic Anemia Report Description The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer. Download Sample Report @ http://www.bigmarketresearch.com/request-sample/22695

  4. Acquired (Autoimmune) Hemolytic Anemia Report Description Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending. Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition. Get enquire about report here @ http://www.bigmarketresearch.com/report-enquiry/22695

  5. Acquired (Autoimmune) Hemolytic Anemia Table Of Contents CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY THERAPEUTIC MODALITIES CHAPTER 5 GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY CANCER TYPES CHAPTER 6 GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY GEOGRAPHY CHAPTER 7 COMPANY PROFILES Read complete TOC @ http://www.bigmarketresearch.com/oncology-cancer-drugs-market

  6. Acquired (Autoimmune) Hemolytic Anemia Report Description KEY BENEFITS The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market Market conditions of cancer drugs market across all geographic regions are comprehensively analyzed Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

  7. Acquired (Autoimmune) Hemolytic Anemia Report Description • MARKET SEGMENTATION • The cancer drugs market is segmented by the therapeutic modalities, cancer types and geography. • MARKET BY THERAPEUTIC MODALITIES • Chemotherapy • Targeted Therapy • Immunotherapy (Biologic Therapy) • Hormonal Therapy • Others • MARKET BY CANCER TYPES • Blood Cancer • Breast Cancer • Gastrointestinal Cancer • Prostate Cancer

  8. Acquired (Autoimmune) Hemolytic Anemia Report Description • MARKET BY GEOGRAPHY • North America • United States • Canada • Mexico • Europe • Germany • France • United Kingdom • Others • Asia-Pacific • India • China • Japan • Australia • Others • LAMEA • GCC (Gulf Corporation Council)

  9. Acquired (Autoimmune) Hemolytic Anemia Report Description • MARKET BY GEOGRAPHY • North America • Europe • Asia-Pacific • LAMEA • Request for Discount @ • http://www.bigmarketresearch.com/purchase-enquiry/22695

  10. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/oncology-cancer-drugs-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related